Hu Zhenzhen, Lee Chung-Il, Han Jin-Yi, Oh Eun-Hye, Ryu Jong-Hoon, Hong Jin Tae, Kim Youngsoo, Oh Ki-Wan
aDepartment of Pathophysiology, College of Medicine, Nanchang University, Jiangxi, China bDepartment of Pharmacy, College of Pharmacy cResearch Institute of Veterinary Medicine, Chungbuk National University, Cheongju dDepartment of Oriental Pharmaceutical Sciences, College of Pharmacy, Kyung-Hee University, Seoul, Republic of Korea.
Behav Pharmacol. 2014 Feb;25(1):32-43. doi: 10.1097/FBP.0000000000000016.
This study examined whether repeated administration of caffeine would induce behavioural sensitization and overexpression of cocaine-regulated and amphetamine-regulated transcript (CART) peptides in mice. The involvement of dopaminergic receptors and adenosine receptors in caffeine-induced behavioural sensitization and CART overexpression was studied. The relevance of D₁R and D₂R, and A₁R and A(2A)R in the overexpression of CART peptides in mouse striatum was also evaluated. Repeated administration of caffeine induced behavioural sensitization in mice. Significant increases in CART mRNA levels were observed on day 3 and peaked at day 5 of caffeine administration, and then decreased gradually. Higher proportions of CART⁺ cells were observed in the dorsolateral and ventrolateral part of the caudate putamen than in the nucleus accumbens shell and core. The behavioural sensitization induced by caffeine was inhibited by dopaminergic receptor antagonists and adenosine receptor agonists. D₁R and D₂R, and cyclic AMP (cAMP)/protein kinase A (PKA)/phospho-cAMP response element-binding protein (pCREB) signalling were activated by caffeine, but A₁R and A(2A)R were inhibited. Overexpression of caffeine-induced CART peptides and pCREB activity were blocked by N-cyclopentyladenosine (CPA, an A₁R agonist) and 4-[2-[[6-amino-9-(N-ethyl-β-D-ribofuranuronamidosyl)-9H-purin-2-yl]amino]ethyl]benzenepropanoic acid hydrochloride (CGS 21680, an A(2A)R agonist), but not by R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH 23390, a D₁R antagonist) or raclopride (a D₂R antagonist). Caffeine-induced overexpression of CART peptides was associated with the inhibition of A₁R and A(2A)R, and the activation of cAMP/PKA/pCREB signalling. Moreover, the A(2A)R-D₂R heterodimer might be involved in the overexpression of CART peptides induced by caffeine.
本研究检测了重复给予咖啡因是否会诱导小鼠行为敏化以及可卡因调节和苯丙胺调节转录物(CART)肽的过表达。研究了多巴胺能受体和腺苷受体在咖啡因诱导的行为敏化和CART过表达中的作用。还评估了D₁R和D₂R以及A₁R和A₂A R在小鼠纹状体中CART肽过表达中的相关性。重复给予咖啡因可诱导小鼠行为敏化。在给予咖啡因的第3天观察到CART mRNA水平显著升高,并在第5天达到峰值,然后逐渐下降。在尾壳核的背外侧和腹外侧部分观察到的CART⁺细胞比例高于伏隔核壳和核心。多巴胺能受体拮抗剂和腺苷受体激动剂可抑制咖啡因诱导的行为敏化。咖啡因可激活D₁R和D₂R以及环磷酸腺苷(cAMP)/蛋白激酶A(PKA)/磷酸化cAMP反应元件结合蛋白(pCREB)信号通路,但抑制A₁R和A₂A R。N-环戊基腺苷(CPA,一种A₁R激动剂)和盐酸4-[2-[[6-氨基-9-(N-乙基-β-D-呋喃核糖酰胺基)-9H-嘌呤-2-基]氨基]乙基]苯丙酸(CGS 21680,一种A₂A R激动剂)可阻断咖啡因诱导的CART肽过表达和pCREB活性,但盐酸R(+)-7-氯-8-羟基-3-甲基-1-苯基-2,3,4,5-四氢-1H-3-苯并氮杂䓬(SCH 23390,一种D₁R拮抗剂)或雷氯必利(一种D₂R拮抗剂)则不能。咖啡因诱导的CART肽过表达与A₁R和A₂A R的抑制以及cAMP/PKA/pCREB信号通路的激活有关。此外,A₂A R-D₂R异二聚体可能参与了咖啡因诱导的CART肽过表达。